![Reid Waldman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 17 M $ al 31/08/2026
Reid Waldman is the founder of Veradermics, Inc., founded in 2019, holding the title of Chief Executive Officer & Director since 2022.
Dr. Waldman currently holds the position of Director at Achieve Life Sciences, Inc., starting in 2026.
Dr. Waldman completed undergraduate and doctorate degrees at the University of Missouri-Kansas City.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/08/2026 | 170.824 ( 0,41 % ) | 17 M $ | 31/08/2026 | |
| 27/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VERADERMICS, INCORPORATED | Fundador | 01/01/2019 |
| ACHIEVE LIFE SCIENCES, INC. | Director/Miembro de la Junta | 29/05/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Missouri-Kansas City
 University of Missouri-Kansas City Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
